David B. Roberts - 18 Feb 2025 Form 4 Insider Report for LEMAITRE VASCULAR INC (LMAT)

Role
President and Director, Director
Signature
/s/ John Pitfield
Issuer symbol
LMAT
Transactions as of
18 Feb 2025
Net transactions value
$0
Form type
4
Filing time
20 Feb 2025, 16:45:24 UTC
Previous filing
26 Dec 2024
Next filing
04 Mar 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LMAT Common Stock Award $0 +129 +0.89% $0.000000 14,671 18 Feb 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LMAT Stock Option (Right to Buy) Award $0 +741 $0.000000 741 18 Feb 2025 Common Stock 741 $100.74 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a restricted stock unit award that vests on a time-based schedule as follows: 25% of the award vests on December 6, 2025, 2026, 2027 and 2028. This award includes a provision for the withholding of shares by the Issuer to pay the withholding taxes due on each vesting date.
F2 This option is exercisable and vests over a four-year period at a rate of 25% on December 6, 2025, 2026, 2027 and 2028.